{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:03:25Z","timestamp":1774321405330,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.medcli.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T01:01:18Z","timestamp":1509498078000},"page":"233-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["El viajero internacional con inmunodepresi\u00f3n farmacol\u00f3gica: retos y oportunidades"],"prefix":"10.1016","volume":"150","author":[{"given":"Belisa","family":"Tarazona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"D\u00edaz-Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Mato Cha\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2017.08.011_bib0300","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tmaid.2014.04.009","article-title":"The medically immunocompromised adult traveler and pre-travel counseling: Status quo 2014","volume":"12","author":"Askling","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.medcli.2017.08.011_bib0305","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1056\/NEJM200006083422306","article-title":"Health advice and immunizations for travelers","volume":"342","author":"Ryan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2017.08.011_bib0310","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/14760584.7.5.663","article-title":"Vaccination and immunization against travel-related diseases in immunocompromised hosts","volume":"7","author":"Kotton","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.medcli.2017.08.011_bib0315","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/infdis\/jiv060","article-title":"Response to hepatitis A vaccination in immunocompromised travelers","volume":"212","author":"Garcia Garrido","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medcli.2017.08.011_bib0320","first-page":"217","article-title":"Travel advice for the immunocompromised traveler: Prophylaxis, vaccination, and other preventive measures","volume":"11","author":"Patel","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.medcli.2017.08.011_bib0325","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4269\/ajtmh.15-0185","article-title":"Immunocompromised travelers: Demographic characteristics, travel destinations, and pretravel health care from the U.S. Global TravEpiNet Consortium","volume":"93","author":"Schwartz","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.medcli.2017.08.011_bib0330","series-title":"Advising travelers with specific needs: Immunocompromised travelers. In: Centers for Disease Control and Prevention. CDC Yellow Book 2018: Health Information for International Travel","author":"Kotton","year":"2017"},{"key":"10.1016\/j.medcli.2017.08.011_bib0335","article-title":"General recommendations on immunization-recommendations of the advisory committee on immunization practices (ACIP). Morbidity and Mortality Weekly Report Centers for Disease Control and Prevention MMWR editorial and production staff","volume":"6060","author":"Frieden","year":"2011","journal-title":"MMWR"},{"key":"10.1016\/j.medcli.2017.08.011_bib0340","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1708-8305.2011.00594.x","article-title":"Health risks of travelers with medical conditions-a retrospective analysis","volume":"19","author":"Wieten","year":"2012","journal-title":"J Travel Med"},{"key":"10.1016\/j.medcli.2017.08.011_bib0345","first-page":"523","article-title":"Travelers with underlying medical conditions","volume":"65","author":"Cailhol","year":"2015","journal-title":"Rev Prat"},{"key":"10.1016\/j.medcli.2017.08.011_bib0350","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1051\/vetres:2005011","article-title":"Important emerging bacterial zoonotic infections affecting the immunocompromised","volume":"36","author":"Trevejo","year":"2005","journal-title":"Vet Res"},{"key":"10.1016\/j.medcli.2017.08.011_bib0355","first-page":"5","article-title":"Vaccination of immune-compromised patients with the focus on patients with autoimmune-inflammatory diseases","volume":"69","author":"Bijl","year":"2011","journal-title":"Neth J Med"},{"key":"10.1016\/j.medcli.2017.08.011_bib0360","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.autrev.2010.12.003","volume":"10","author":"Van Assen","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2017.08.011_bib0365","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cgh.2011.10.025","article-title":"Travel-associated health risks for patients with inflammatory bowel disease","volume":"10","author":"Ben-Horin","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.medcli.2017.08.011_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taw001","article-title":"Travel-related health risks in moderately and severely immunocompromised patients: A case-control study","volume":"23","author":"Dekkiche","year":"2016","journal-title":"J Travel Med"},{"key":"10.1016\/j.medcli.2017.08.011_bib0375","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/imj.12753","article-title":"International travel in the immunocompromised patient: A cross-sectional survey of travel advice in 254 consecutive patients","volume":"45","author":"Bialy","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.medcli.2017.08.011_bib0380","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2310\/7060.2004.13633","article-title":"Travel patterns and risk behavior in solid organ transplant recipients","volume":"11","author":"Boggild","year":"2004","journal-title":"J Travel Med"},{"key":"10.1016\/j.medcli.2017.08.011_bib0385","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.aogh.2016.12.004","article-title":"International travelers\u2019 sociodemographic, health, and travel characteristics: An Italian study","volume":"83","author":"Troiano","year":"2017","journal-title":"Ann Glob Health"},{"key":"10.1016\/j.medcli.2017.08.011_bib0390","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad-Profesionales-La salud tambi\u00e9n viaja-Consejos para el viajero [Internet] [consultado 20 Jul 2017]. Disponible en: https:\/\/www.msssi.gob.es\/profesionales\/saludPublica\/sanidadExterior\/salud\/consejosViajero.htm"},{"key":"10.1016\/j.medcli.2017.08.011_bib0395","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medcli.2017.08.011_bib0400","unstructured":"Ponencia de programas y registro de vacunaciones. Revisi\u00f3n del calendario de vacunaci\u00f3n. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad, 2016 [consultado 20 Jul 2017]. Disponible en: https:\/\/www.msssi.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/Revision_CalendarioVacunacion.pdf"},{"key":"10.1016\/j.medcli.2017.08.011_bib0405","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1696-2818(13)70122-7","article-title":"Vacunaci\u00f3n en pacientes con enfermedades reumatol\u00f3gicas","volume":"11","author":"Fern\u00e1ndez Silveira","year":"2013","journal-title":"An Pediatr Contin"},{"key":"10.1016\/j.medcli.2017.08.011_bib0410","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.semarthrit.2003.10.003","article-title":"The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"33","author":"Elkayam","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.medcli.2017.08.011_bib0415","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J Crohns Colitis"},{"issue":"Suppl 2","key":"10.1016\/j.medcli.2017.08.011_bib0420","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1136\/annrheumdis-2013-203348","article-title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012","volume":"72","author":"Furst","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2017.08.011_bib0425","first-page":"w14159","article-title":"Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases","volume":"145","author":"B\u00fchler","year":"2015","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.medcli.2017.08.011_bib0430","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5114\/reum.2016.64901","article-title":"Vaccinations in autoimmune inflammatory rheumatic diseases","volume":"54","author":"Szenborn","year":"2016","journal-title":"Reumatologia"},{"key":"10.1016\/j.medcli.2017.08.011_bib0435","first-page":"36","article-title":"Inmunizaci\u00f3n y quimioprofilaxis en pacientes con artritis reumatoide","volume":"14","author":"Begazo Cruz","year":"2013","journal-title":"Semin Fund Esp Reumatol"},{"key":"10.1016\/j.medcli.2017.08.011_bib0440","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-128-2-199801150-00006","article-title":"Serious hepatitis A: An analysis of patients hospitalized during an urban epidemic in the United States","volume":"128","author":"Willner","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medcli.2017.08.011_bib0445","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.3748\/wjg.v21.i11.3184","article-title":"Updates in vaccination: recommendations for adult inflammatory bowel disease patients","volume":"21","author":"Chaudrey","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.medcli.2017.08.011_bib0450","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.vaccine.2013.10.088","article-title":"Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults","volume":"32","author":"Hens","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.medcli.2017.08.011_bib0455","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/jmv.21883","article-title":"Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine","volume":"82","author":"Bovier","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.medcli.2017.08.011_bib0460","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200102150-00023","article-title":"Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients","volume":"71","author":"G\u00fcnther","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.medcli.2017.08.011_bib0465","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.vaccine.2006.08.044","article-title":"Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population","volume":"25","author":"Rendi-Wagner","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.medcli.2017.08.011_bib0470","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tmaid.2014.01.005","article-title":"Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study","volume":"12","author":"Askling","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.medcli.2017.08.011_bib0475","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00007890-200107270-00019","article-title":"Safety and efficacy of hepatitis A vaccination in liver transplantation recipients","volume":"72","author":"Arslan","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.medcli.2017.08.011_bib0480","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1086\/315125","article-title":"Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients","volume":"180","author":"Stark","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medcli.2017.08.011_bib0485","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Japanese encephalitis vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Fischer","year":"2010","journal-title":"MMWR Recomm reports Morb Mortal Wkly report Recomm reports"},{"key":"10.1016\/j.medcli.2017.08.011_bib0490","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.vaccine.2015.12.029","article-title":"Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study","volume":"34","author":"Hertzell","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.medcli.2017.08.011_bib0495","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.285.12.1574","article-title":"Postexposure rabies prophylaxis in immunosuppressed patients","volume":"285","author":"Gibbons","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2017.08.011_bib0500","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: Recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"MMWR Recomm reports Morb Mortal Wkly Report Recomm Reports"},{"key":"10.1016\/j.medcli.2017.08.011_bib0505","unstructured":"Centers for Disease Control and Prevention (CDC). Updated recommendations for use of meningococcal conjugate vaccines ---Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2011;60:72-6."},{"key":"10.1016\/j.medcli.2017.08.011_bib0510","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/ard.61.7.623","article-title":"Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis","volume":"61","author":"Elkayam","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2017.08.011_bib0515","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.vaccine.2013.04.059","article-title":"Factors predicting response to hepatitis B vaccination in patients with inflammatory bowel disease","volume":"31","author":"Sempere","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.medcli.2017.08.011_bib0520","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/ajg.2012.79","article-title":"Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease","volume":"107","author":"Gisbert","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.medcli.2017.08.011_bib0525","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastrohep.2012.04.006","article-title":"Consensus document of the Spanish Association for the Study of the Liver on the treatment of hepatitis B infection (2012)","volume":"35","author":"Buti","year":"2012","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.medcli.2017.08.011_bib0530","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: Immunization of adults","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm reports Morb Mortal Wkly Report Recomm Reports"},{"key":"10.1016\/j.medcli.2017.08.011_bib0535","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2017.03.011","article-title":"Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis","volume":"80","author":"Lopez","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.medcli.2017.08.011_bib0540","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00296-013-2907-9","article-title":"Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases","volume":"34","author":"Papadopoulou","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.medcli.2017.08.011_bib0545","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0885066615610108","article-title":"Use of a cholestyramine washout in a patient with septic shock on leflunomide therapy: A Case report and review of the literature","volume":"31","author":"Laub","year":"2016","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.medcli.2017.08.011_bib0550","series-title":"Infectious diseases related to travel: Yellow fever. In: Centers for Disease Control and Prevention. CDC Yellow Book 2018: Health Information for International Travel","author":"Gershman","year":"2017"},{"key":"10.1016\/j.medcli.2017.08.011_bib0555","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1016\/j.vaccine.2010.09.009","article-title":"Vaccine preventable diseases in returned international travelers: Results from the GeoSentinel Surveillance Network","volume":"28","author":"Boggild","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.medcli.2017.08.011_bib0560","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa051331","article-title":"Spectrum of disease and relation to place of exposure among ill returned travelers","volume":"354","author":"Freedman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2017.08.011_bib0565","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1708-8305.2011.00543.x","article-title":"Symptoms of infectious diseases in immunocompromised travelers: A prospective study with matched controls","volume":"18","author":"Baaten","year":"2011","journal-title":"J Travel Med"},{"key":"10.1016\/j.medcli.2017.08.011_bib0570","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1399-3062.2012.00719.x","article-title":"Cryptosporidium enteritis in solid organ transplant recipients: multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations","volume":"14","author":"Bonatti","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.medcli.2017.08.011_bib0575","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1053\/j.gastro.2006.02.004","article-title":"Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease","volume":"130","author":"Rodr\u00edguez","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.medcli.2017.08.011_bib0580","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mcna.2015.08.017","article-title":"Traveler's diarrhea","volume":"100","author":"Giddings","year":"2016","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.medcli.2017.08.011_bib0585","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-158-6-201303190-00005","article-title":"GeoSentinel surveillance of illness in returned travelers, 2007-2011","volume":"158","author":"Leder","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medcli.2017.08.011_bib0590","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317307182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317307182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T18:30:12Z","timestamp":1530642612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775317307182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0025775317307182"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.08.011","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"El viajero internacional con inmunodepresi\u00f3n farmacol\u00f3gica: retos y oportunidades","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}